Bone Diseases, Metabolic: Clinical Trials

2,343 trials for Bone Diseases, Metabolic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1511 completed, 346 unknown, 163 recruiting, 97 terminated. 737 Not applicable, 291 Phase 3, 273 Phase 4, 245 Phase 2, 161 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable737Completed 464, Unknown 102, Recruiting 59, Active not recruiting 32, Not yet recruiting 30, Terminated 26, Withdrawn 18, Suspended 4, Enrolling by invitation 2
Phase 3291Completed 240, Unknown 25, Terminated 16, Withdrawn 8, Enrolling by invitation 1, Recruiting 1
Phase 4273Completed 182, Unknown 37, Recruiting 16, Active not recruiting 11, Terminated 11, Withdrawn 8, Not yet recruiting 7, Enrolling by invitation 1
Phase 2245Completed 168, Unknown 25, Terminated 18, Withdrawn 12, Active not recruiting 7, Recruiting 7, Not yet recruiting 5, Enrolling by invitation 3
Phase 1161Completed 117, Unknown 21, Terminated 8, Withdrawn 5, Not yet recruiting 3, Recruiting 3, Active not recruiting 2, Enrolling by invitation 2
Early Phase 116Completed 12, Unknown 2, Recruiting 1, Withdrawn 1

Follow Bone Diseases, Metabolic: new trials by email Literature Review of Bone Diseases, Metabolic trials Research Report on Bone Diseases, Metabolic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD
Romosozumab, Zoledronic Acid 5 MG in 5 ML Injection, Calcium 500 mg and Vitamin D3 800 IU - Osteoporosis in Post-menopausal Women
Phase 4Not yet recruitingSahlgrenska University Hospital2162027-01-112026-08-19
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Endothelial cell collection - Obesity and Obesity-related Medical Conditions, Diabetes
RecruitingBettina Mittendorfer1002027-01-012026-05-07
Romosozumab and Denosumab Combination Therapy for Osteoporosis
Romosozumab, Romosozumab and Denosumab - Postmenopausal Osteoporosis
Phase 4Not yet recruitingMassachusetts General Hospital1002027-01-012026-11-03
Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis
Exercise training - Osteopenia, Osteoporosis
Not applicableWithdrawnUniversity of Alabama at Birmingham2026-12-012026-07-01
Post-osteoporotic Fracture Exercise Program
Exercise Program - Osteoporosis, Osteoporotic Fracture
Not applicableRecruitingWestern University, Canada1002026-12-012026-11-10
Melatonin in Posterior Mandible Extraction Socket
Melatonin group, Placebo group - Bone Loss
Phase 2Not yet recruitingCairo University402026-11-152026-11-06
Time-Restricted Eating and Exercise for Bone Health
Time-restricted eating combined with resistance exercise (TRE+Ex), Habitual eating pattern combined with resistance exercise (HE+Ex) - Osteopenia
Not applicableNot yet recruitingUniversity of Alabama at Birmingham242026-11-012026-09-17
Exercise and Fall Prevention for Fracture Reduction
Guideline-based home exercise training - Osteopenia, Osteoporosis
Not applicableNot yet recruitingWolfgang Kemmler, PhD722026-11-012026-10-29
Study of TST002 Injection in Postmenopausal Women With Osteoporosis or Low Bone Mass
Denosumab, Placebo - Postmenopausal Osteoporosis, Low Bone Mass
Phase 2Not yet recruitingTranscenta Therapeutics (Hangzhou) Co., Ltd.1102026-10-312026-09-11
REducing Systemic Inflammation With LOw-dose Colchicine to ImproVE Cardiovascular Calcification in Chronic Kidney Disease: A Pilot Randomized Open-Label Trial
Low-dose Colchicine at 0.5mg daily, Usual Care - Chronic Kidney Disease Mineral and Bone Disorder, Cognitive Function
Phase 2Not yet recruitingUniversity of Texas Southwestern Medical Center602026-10-302026-11-04
Bone Deterioration After Kidney Transplantation Assessed by DXA and HR-pQCT
DXA and HR-pQCT, Blood and urine sampling - Kidney Transplantation, Bone Loss
RecruitingMedical University Innsbruck1002026-10-212026-11-13
A Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral Compression Fractures of (Suspected) Osteoporotic Origin.
VCFix Spinal System in stand-alone configuration - Vertebra Compression Fracture
RecruitingAmber Implants B.V.302026-10-042026-11-05
Osteoporosis & Renal Disease: Research in Primary Health Care Services
Fracture risk assessment tool (FRAX), Dual-Energy X-ray Absorptiometry (DXA) - Osteoporosis, Chronic Kidney Disease Mineral and Bone Disorder
Not yet recruitingUniversidade do Porto6222026-10-012026-09-30
Controlled Reduction of AO Spine B3 Fractures in Ankylosing Spinal Disorders Using an Inflatable Positioning Device: Technical Note and Retrospective Single-centre Case Series
Spine Fracture, Osteoporosis
Not yet recruitingDiakonie-Klinikum Stuttgart232026-09-202026-09-29
Comparison of Induced Membrane Technique With Vascularized Fibula Flap for Pediatric Limb Reconstruction
limb reconstruction - Bone Loss, Microsurgery
Not yet recruitingCentral Hospital, Nancy, France1402026-09-152026-09-17
Bone and Muscle Oxygenation in Military Test Pilots
Supervised Resistance and Core Stabilization Exercise Program - Low Bone Mineral Density, Muscle Oxygenation
Not applicableNot yet recruitingEmine Merve Ersever102026-09-152026-08-26
Access to Probing and Peri-implant Diseases
Peri-implant probing - Peri-implantitis, Peri-implant Bone Loss
RecruitingArrow Development2812026-09-012026-10-13
Calcium-Rich Food Versus Calcium Carbonate for Bone Health
500 mg calcium from milk-derived minerals, Calcium Carbonate 500 MG - Osteopenia, Osteoporosis
Not applicableNot yet recruitingCornell University2172026-09-012026-08-13
Romosozumab Versus Denosumab In Glucocorticoid-induced Osteoporosis: An Extended Observation Of a Clinical Trial at 6 Years
Romosozumab, Denosumab - Glucocorticoid-Associated Osteopenia and Osteoporosis
Phase 4Not yet recruitingTuen Mun Hospital542026-09-012026-08-12
Full-Spectrum Cannabis Extract for Chronic Pain and Bone Health Biomarkers in Women
Full-Spectrum Cannabis Extract 5:1 (CBD:THC) - Chronic Pain, Fibromyalgia
Phase 2Not yet recruitingAssociação Pan-Americana Multidisciplinar de Endocanabinologia802026-09-012026-08-26

Showing 20 of 2343. Sign in to see all of them.

Narrower conditions

Osteoporosis (1557)  ·  Osteoporosis, Postmenopausal (332)  ·  Fractures, Bone (139)  ·  Sarcopenia (76)  ·  Chronic Kidney Disease-Mineral and Bone Disorder (74)  ·  Motor Activity (74)  ·  Diabetes Mellitus (54)  ·  Breast Neoplasms (53)  ·  Osteoporotic Fractures (53)  ·  Hip Fractures (52)  ·  Bone Diseases (51)  ·  Renal Insufficiency, Chronic (51)  ·  Obesity (50)  ·  Spinal Fractures (50)

Broader conditions

Nutritional and Metabolic Diseases (2342)  ·  Metabolic Diseases (2334)  ·  Musculoskeletal Diseases (2322)  ·  Bone Diseases (2292)  ·  Pathological Conditions, Signs and Symptoms (417)  ·  Wounds and Injuries (308)  ·  Nutrition Disorders (265)  ·  Urogenital Diseases (253)  ·  Endocrine System Diseases (235)  ·  Pathologic Processes (222)  ·  Signs and Symptoms (222)  ·  Nervous System Diseases (214)  ·  Deficiency Diseases (211)  ·  Avitaminosis (209)

Interventions

Denosumab (121)  ·  Alendronate (114)  ·  Teriparatide (108)  ·  Zoledronic Acid (103)  ·  Cholecalciferol (88)  ·  Vitamin D (83)  ·  Calcium (73)  ·  Risedronic Acid (72)  ·  Exercise (48)  ·  Absorptiometry, Photon (45)  ·  Calcium Carbonate (42)  ·  Ibandronic Acid (42)  ·  romosozumab (34)  ·  Resistance Training (28)  ·  Raloxifene Hydrochloride (26)

Sponsors

Amgen (49)  ·  Eli Lilly and Company (45)  ·  National Taiwan University Hospital (33)  ·  Cairo University (31)  ·  Massachusetts General Hospital (31)  ·  GlaxoSmithKline (24)  ·  Hoffmann-La Roche (24)  ·  Merck Sharp & Dohme LLC (24)  ·  Novartis Pharmaceuticals (23)  ·  University of Aarhus (22)  ·  Organon and Co (19)  ·  University of Alabama at Birmingham (18)  ·  Columbia University (16)  ·  Mayo Clinic (16)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (15)

Countries

United States (715)  ·  Canada (163)  ·  France (147)  ·  China (122)  ·  Denmark (119)  ·  Turkey (Türkiye) (99)  ·  United Kingdom (99)  ·  Germany (98)  ·  Italy (95)  ·  Spain (87)  ·  Egypt (76)  ·  Taiwan (67)  ·  Poland (61)  ·  Japan (58)  ·  South Korea (57)

Top investigators

Mustafa H Temel, M.D. (10)  ·  Thomas J Schnitzer, MD, PhD (7)  ·  Benjamin Leder, MD (5)  ·  Connie M Weaver, PhD (5)  ·  Ding-Cheng Chan, MD, PhD (5)

Results publications

PMID 38979716, PMID 39151033, PMID 21037195, PMID 34231877, PMID 26529632, PMID 40576086, PMID 12795371, PMID 31776637, PMID 32417537, PMID 32721016, PMID 32762706, PMID 33305842, PMID 40962182, PMID 11138687, PMID 16018754, PMID 18539106, PMID 18634158, PMID 19362675, PMID 20533525, PMID 21062463, PMID 21148044, PMID 21289258, PMID 21544866, PMID 22152181, PMID 23013236, PMID 23803880, PMID 25030780, PMID 25179289, PMID 25475435, PMID 25527752, PMID 25919461, PMID 26869384, PMID 27072861, PMID 27385761, PMID 27557655, PMID 27680993, PMID 27699270, PMID 28473464, PMID 28487349, PMID 28546097, PMID 29105841, PMID 29141853, PMID 29605469, PMID 29661934, PMID 30334093, PMID 31411768, PMID 31665314, PMID 31674644, PMID 32658264, PMID 33249320

NIH funding

2008 (5), 2009 (5), 2016 (5), 2018 (4), 2005 (3), 2014 (3), 2025 (3), P50AR044855 (3), P50AT000090 (3), R44AG017400 (3), 2015 (2), 2017 (2), 2023 (2), N01AR002245 (2), R01DK032333 (2)